Published in Arch Gynecol Obstet on September 01, 2012
Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry. J Cancer Res Clin Oncol (2015) 0.81
Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy-results from the prospective multi-center study BRENDA II. Support Care Cancer (2016) 0.80
Tumor characteristics and therapy of elderly patients with breast cancer. J Cancer Res Clin Oncol (2016) 0.76
Risk of contralateral second primary breast cancer according to hormone receptor status in Germany. Breast Cancer Res (2014) 0.76
Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ (2005) 4.91
Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med (1992) 4.86
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res (2007) 4.41
Biased estimation of the odds ratio in case-control studies due to the use of ad hoc methods of correcting for missing values for confounding variables. Am J Epidemiol (1991) 3.72
Controlling for continuous confounders in epidemiologic research. Epidemiology (1997) 3.42
Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res (2000) 2.83
Human ovarian tissue cryopreservation: quality of follicles as a criteria of effectiveness. Reprod Biomed Online (2010) 2.46
Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem (2000) 2.06
p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer. Lancet (1995) 1.84
Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol (1999) 1.84
Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer (1999) 1.83
A reverse genetic approach for generating gene replacement mutants in Ustilago maydis. Mol Genet Genomics (2004) 1.75
Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol (2002) 1.72
High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial. J Clin Oncol (2004) 1.70
Is cancer risk of radiation workers larger than expected? Occup Environ Med (2009) 1.70
cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem (1996) 1.66
Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res (1988) 1.66
Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study. J Clin Endocrinol Metab (2014) 1.63
Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: role of infusion schedule and costimulation with cytokines. Clin Cancer Res (2001) 1.62
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. Clin Cancer Res (2001) 1.59
Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol (1999) 1.58
Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects. Ann Oncol (2005) 1.58
Comparing imperfect measures of exposure. Am J Epidemiol (1985) 1.48
Long-term morbidity following axillary dissection in breast cancer patients--clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat (2000) 1.45
p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol (1999) 1.45
Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation (2001) 1.43
Human ovarian tissue vitrification versus conventional freezing: morphological, endocrinological, and molecular biological evaluation. Reproduction (2009) 1.42
[Diabetes screening in pregnant patients with different risk factors. Benefits, therapeutic success, consequences]. Z Geburtshilfe Neonatol (1996) 1.39
[Follow-up of tumor markers in evaluating the effectiveness of chemo- or hormone therapy in metastatic breast cancer]. Geburtshilfe Frauenheilkd (1993) 1.39
Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study. Eur Heart J (1991) 1.39
[Cancer incidence rate after diagnostic X-ray exposure in 1976 - 2003 among patients of a university children's hospital]. Rofo (2010) 1.38
The 15-Country Collaborative Study of Cancer Risk Among Radiation Workers in the Nuclear Industry: design, epidemiological methods and descriptive results. Radiat Res (2007) 1.37
The function of the chloroplast 2-cysteine peroxiredoxin in peroxide detoxification and its regulation. J Exp Bot (2002) 1.34
Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. Ann Oncol (2009) 1.33
Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol (2002) 1.32
Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience (2004) 1.30
Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst (1987) 1.28
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics (2001) 1.23
Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. Int J Cancer (2001) 1.23
Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med (2001) 1.22
An international case-control study of adult glioma and meningioma: the role of head trauma. Int J Epidemiol (1998) 1.22
Familial aggregation of oesophageal cancer in a high incidence area in China. Int J Epidemiol (1997) 1.18
Medical risk factors and the development of brain tumors. Cancer (1992) 1.18
Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings. AJR Am J Roentgenol (2001) 1.17
Trends in maternal mortality ratio among women of German and non-German nationality in West Germany, 1980-1996. Int J Epidemiol (1999) 1.17
Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol (1997) 1.17
Computed tomography in children: multicenter cohort study design for the evaluation of cancer risk. Eur J Epidemiol (2011) 1.17
Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma. Scand J Immunol (2006) 1.17
[The Gutenberg Health Study]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2012) 1.15
Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol Pharmacol (2001) 1.14
Occupational risk factors for brain tumors: results from a population-based case-control study in Germany. Cancer Causes Control (1990) 1.14
Mobile phone base stations and adverse health effects: phase 2 of a cross-sectional study with measured radio frequency electromagnetic fields. Occup Environ Med (2009) 1.14
Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients. Breast Cancer Res Treat (2013) 1.14
Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients. Breast Cancer Res Treat (2010) 1.13
p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Anticancer Res (1998) 1.13
Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst (1992) 1.10
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44). Ann Oncol (2013) 1.09
The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress. J Neurochem (2001) 1.09
Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines. Int J Cancer (1992) 1.08
MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol (1997) 1.08
Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil. Clin Chem (2001) 1.06
Measurement error correction using validation data: a review of methods and their applicability in case-control studies. Stat Methods Med Res (2000) 1.06
Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system. Neuroscience (2005) 1.06
Birth defects among children born to a population occupationally exposed to pesticides in Colombia. Scand J Work Environ Health (1990) 1.05
Cosmic radiation and cancer mortality among airline pilots: results from a European cohort study (ESCAPE). Radiat Environ Biophys (2003) 1.05
Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer. Gynecol Oncol (2008) 1.05
Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med (1997) 1.05
Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass. Br J Cancer (2000) 1.04
Logistic regression with incompletely observed categorical covariates--investigating the sensitivity against violation of the missing at random assumption. Stat Med (1995) 1.04
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. Br J Cancer (1999) 1.03
The Patient Assessment of Chronic Illness Care questionnaire: evaluation in patients with mental disorders in primary care. Community Ment Health J (2010) 1.03
PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme. Oncogene (2001) 1.02
Hepatic secretion of conjugated drugs and endogenous substances. Semin Liver Dis (2000) 1.01
Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study. Breast Cancer Res Treat (2011) 1.01
Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial. Ultrasound Obstet Gynecol (2000) 1.01
Regulation of endothelial proliferation by the renin-angiotensin system in human umbilical vein endothelial cells. Reproduction (2008) 1.01
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group. J Clin Oncol (1989) 1.00
Type D personality as a cardiovascular risk marker in the general population: results from the Gutenberg health study. Psychother Psychosom (2012) 1.00
Correlation between oral health and body mass index (BMI) in 2071 primary school pupils. Eur J Med Res (2007) 1.00
Ultrasound-guided large-core needle biopsies of breast lesions: analysis of 962 cases to determine the number of samples for reliable tumour classification. Br J Cancer (2005) 1.00
T grafts with the right internal thoracic artery to left internal thoracic artery versus the left internal thoracic artery and radial artery: flow dynamics in the internal thoracic artery main stem. J Thorac Cardiovasc Surg (1999) 1.00
Misclassification bias arising from random error in exposure measurement: implications for dual measurement strategies. Am J Epidemiol (1993) 0.99
Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene. Eur J Biochem (2000) 0.99
Long-term results after operative correction of vaginal aplasia. Am J Obstet Gynecol (1996) 0.98
Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. Eur J Surg Oncol (2004) 0.98
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial. Ann Oncol (2010) 0.98
Incidence of childhood cancer of the head and neck in Germany. Ann Oncol (2007) 0.98
Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J Am Soc Nephrol (1999) 0.97
Kondo effect in quantum dots coupled to ferromagnetic leads. Phys Rev Lett (2003) 0.97
Inhibition of mouse erythroid band 3-mediated chloride transport by site-directed mutagenesis of histidine residues and its reversal by second site mutation of Lys 558, the locus of covalent H2DIDS binding. Biochemistry (1995) 0.96